Group II introns are ribozymes with a diversity of biological functions: They are self-splicing RNA molecules that also behave as transposable elements. Their mobility among genomes is one plausible explanation for the dispersal of introns throughout eukaryotic organisms and they are widely believed to represent an ancestral form of the eukaryotic spliceosome. Research on group II introns therefore provides important insights into general splicing mechanisms and is leading to the development of targeted introns for potential application in biotechnology and gene therapy. At a more basic level, group II introns have an unusual architecture that is providing a wealth of information on RNA folding and tertiary structure. In order to apply group II introns in biomedical land basic research, and to better understand how they function in splicing and mobility, we must be able to visualize their three-dimensional architecture. It is particularly important to understand the structure of the intron active-site, branch-site and surrounding catalytic core. To this end, we propose a series of experiments designed to elucidate the spatial organization and function of critical group II intron domains 1,2, 5 and 6, by emphasizing a combination of chemogenetic methodologies (nucleotide analog interference suppression), site-directed crosslinking, molecular modeling and crystallography. A diverse family of group II introns will be investigated in order to exploit the unique thermostability, ionic requirements and mechanistic features that are provided by individual examples. By combining biochemical and biophysical methods in this manner, we hope to obtain structural information that reflects active and biologically informative conformations of the group II intron.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM050313-10
Application #
6573636
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Lewis, Catherine D
Project Start
1994-01-01
Project End
2006-12-31
Budget Start
2003-01-20
Budget End
2003-12-31
Support Year
10
Fiscal Year
2003
Total Cost
$231,613
Indirect Cost
Name
Yale University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Zhao, Chen; Liu, Fei; Pyle, Anna Marie (2018) An ultraprocessive, accurate reverse transcriptase encoded by a metazoan group II intron. RNA 24:183-195
Fedorova, Olga; Jagdmann Jr, G Erik; Adams, Rebecca L et al. (2018) Small molecules that target group II introns are potent antifungal agents. Nat Chem Biol 14:1073-1078
Liu, Fei; Somarowthu, Srinivas; Pyle, Anna Marie (2017) Visualizing the secondary and tertiary architectural domains of lncRNA RepA. Nat Chem Biol 13:282-289
Dickey, Thayne H; Pyle, Anna M (2017) The SMAD3 transcription factor binds complex RNA structures with high affinity. Nucleic Acids Res 45:11980-11988
Zhao, Chen; Pyle, Anna Marie (2017) Structural Insights into the Mechanism of Group II Intron Splicing. Trends Biochem Sci 42:470-482
Zhao, Chen; Pyle, Anna Marie (2017) The group II intron maturase: a reverse transcriptase and splicing factor go hand in hand. Curr Opin Struct Biol 47:30-39
Zhao, Chen; Pyle, Anna Marie (2016) Crystal structures of a group II intron maturase reveal a missing link in spliceosome evolution. Nat Struct Mol Biol 23:558-65
Somarowthu, Srinivas (2016) Progress and Current Challenges in Modeling Large RNAs. J Mol Biol 428:736-747
Pyle, Anna Marie (2016) Group II Intron Self-Splicing. Annu Rev Biophys 45:183-205
Marcia, Marco (2016) Using Molecular Replacement Phasing to Study the Structure and Function of RNA. Methods Mol Biol 1320:233-57

Showing the most recent 10 out of 62 publications